DNA Link Inc. (127120)

Overview

DNA Link, Inc., established in 2000 with its headquarters in Seoul, South Korea, stands at the forefront of the biotechnology sector, emphasizing genome-based research and development efforts. This enterprise has expanded its horizons beyond South Korea, delivering its innovative services on an international scale. At its core, DNA Link, Inc. is dedicated to harnessing the power of genome analysis to push the boundaries of scientific understanding and application. The company is committed to providing a broad array of next-generation sequencing and other genomic services to meet the diverse needs of its clientele, ranging from academic institutions to industry sectors. With a strong focus on quality, innovation, and customer service, DNA Link, Inc. continues to contribute significantly to the advancement of genomics research and its practical applications in various fields.

Products and Services

• Whole Genome Sequencing

  This service provides comprehensive analysis of an individual's or organism's entire genome, offering invaluable insights for research, diagnostics, and personalized medicine.

• De Novo Sequencing

  Ideal for organisms without a reference genome, De Novo sequencing allows for the assembly and analysis of a new genome from scratch, facilitating discoveries in genetics and molecular biology.

• Whole Exome/Targeted Sequencing

  By focusing on the exome or specific genomic regions, this service enables more focused and cost-effective analysis for identifying genetic variations associated with diseases.

• Transcriptome Sequencing

  This technique maps out the entire transcriptome, providing insights into gene expression patterns under various conditions and contributing to our understanding of diseases and development.

• Epigenome Sequencing

  Epigenome sequencing explores the chemical modifications of the DNA and histone proteins, influencing gene expression levels without altering the underlying DNA sequence.

• Single-Cell RNA Sequencing

  Offering a high-resolution view of the transcriptomic activity in individual cells, this technology enables the analysis of cellular heterogeneity within tissues and the identification of novel cell types.

• Microarray Services

  DNA and RNA microarray analyses allow for the measurement of gene expression across thousands of genes simultaneously, supporting large-scale genetic studies and biomarker discovery.

• Fluidigm BioMark System

  An automated system for high-throughput PCR/qPCR, allowing for precise quantification of nucleic acids and efficient validation of genetic markers.

• TaqMan Assay

  A widely used real-time PCR technique, the TaqMan assay supports the detection and quantification of specific genetic sequences, valuable in research and clinical diagnostics.

• SNaPshot Assay

  This method is used for the detection of known genetic mutations, enabling genotyping and mutation analysis across various genes in a single experiment.

• Covid-19 Diagnostic Kits

  Responding to the global pandemic, DNA Link offers diagnostic solutions for detecting SARS-CoV-2, employing rigorous testing to ensure accuracy and reliability.

• DNAGPS (Personal Genomics Solution)

  DNAGPS provides personalized genomics information, helping individuals understand their genetic predispositions towards certain conditions and traits, thereby promoting personalized healthcare strategies.

• AccuID (Personal Identification Microarray System)

  This product offers a robust solution for personal identification and forensic analysis, leveraging the power of microarray technology to achieve accurate and comprehensive genetic profiling.